Open AccessThe clinical implications of left ventricular diastolic dysfunction in systemic sclerosis
Author(s) -
Laura Ross,
Shreeya Patel,
Wendy Stevens,
Andrew Burns,
David B. Prior,
André La Gerche,
Mandaikpour
Publication year - 2022
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/irc0ih
Subject(s) - medicine , cardiology , heart failure , diastole , ejection fraction , systemic scleroderma , diastolic function , cohort , blood pressure , disease
We sought to quantify the burden of left ventricular diastolic dysfunction (LVDD) and heart failure with preserved ejection fraction (HFpEF) in systemic sclerosis (SSc) and assess the progression of LVDD over time and its prognostic importance.